169 related articles for article (PubMed ID: 33865087)
1. Commensal flora triggered target anti-inflammation of alginate-curcumin micelle for ulcerative colitis treatment.
Wang Y; Li Y; He L; Mao B; Chen S; Martinez V; Guo X; Shen X; Liu B; Li C
Colloids Surf B Biointerfaces; 2021 Jul; 203():111756. PubMed ID: 33865087
[TBL] [Abstract][Full Text] [Related]
2. Galactosylated alginate-curcumin micelles for enhanced delivery of curcumin to hepatocytes.
Sarika PR; James NR; Kumar PR; Raj DK
Int J Biol Macromol; 2016 May; 86():1-9. PubMed ID: 26774374
[TBL] [Abstract][Full Text] [Related]
3. Colon-targeted hydroxyethyl starch-curcumin microspheres with high loading capacity ameliorate ulcerative colitis via alleviating oxidative stress, regulating inflammation, and modulating gut microbiota.
Huang D; Wang Y; Xu C; Zou M; Ming Y; Luo F; Xu Z; Miao Y; Wang N; Lin Z; Weng Z
Int J Biol Macromol; 2024 May; 266(Pt 1):131107. PubMed ID: 38527677
[TBL] [Abstract][Full Text] [Related]
4. "Dual sensitive supramolecular curcumin nanoparticles" in "advanced yeast particles" mediate macrophage reprogramming, ROS scavenging and inflammation resolution for ulcerative colitis treatment.
Han X; Luo R; Qi S; Wang Y; Dai L; Nie W; Lin M; He H; Ye N; Fu C; You Y; Fu S; Gao F
J Nanobiotechnology; 2023 Sep; 21(1):321. PubMed ID: 37679849
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic and prophylactic role of vitamin D and curcumin in acetic acid-induced acute ulcerative colitis model.
Erarslan AS; Ozmerdivenli R; Sirinyıldız F; Cevik O; Gumus E; Cesur G
Toxicol Mech Methods; 2023 Nov; 33(6):480-489. PubMed ID: 36872571
[TBL] [Abstract][Full Text] [Related]
6. Analysis of toxicity and anticancer activity of micelles of sodium alginate-curcumin.
Karabasz A; Lachowicz D; Karewicz A; Mezyk-Kopec R; Stalińska K; Werner E; Cierniak A; Dyduch G; Bereta J; Bzowska M
Int J Nanomedicine; 2019; 14():7249-7262. PubMed ID: 31564877
[TBL] [Abstract][Full Text] [Related]
7. Metformin and curcumin co-encapsulated chitosan/alginate nanoparticles as effective oral carriers against pain-like behaviors in mice.
Dasuni Wasana PW; Hasriadi ; Vajragupta O; Rojsitthisak P; Towiwat P; Rojsitthisak P
Int J Pharm; 2023 Jun; 640():123037. PubMed ID: 37172632
[TBL] [Abstract][Full Text] [Related]
8. Enhancing stability and anti-inflammatory properties of curcumin in ulcerative colitis therapy using liposomes mediated colon-specific drug delivery system.
Wang C; Han Z; Wu Y; Lu X; Tang X; Xiao J; Li N
Food Chem Toxicol; 2021 May; 151():112123. PubMed ID: 33744379
[TBL] [Abstract][Full Text] [Related]
9. Oral delivery of curcumin via multi-bioresponsive polyvinyl alcohol and guar gum based double-membrane microgels for ulcerative colitis therapy.
Hu Y; Zhang S; Wen Z; Fu H; Hu J; Ye X; Kang L; Li X; Yang X
Int J Biol Macromol; 2022 Nov; 221():806-820. PubMed ID: 36099999
[TBL] [Abstract][Full Text] [Related]
10. Oral delivery of porous starch-loaded bilayer microgels for controlled drug delivery and treatment of ulcerative colitis.
Wen Z; Kang L; Fu H; Zhu S; Ye X; Yang X; Zhang S; Hu J; Li X; Chen L; Hu Y; Yang X
Carbohydr Polym; 2023 Aug; 314():120887. PubMed ID: 37173037
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Macrophages with Inflammatory Reaction in Ulcerative Colitis and Influence of Curcumin on Macrophage Chemotaxis.
Chen Y; Chen D; Zhou C; Cao X; He J
Altern Ther Health Med; 2023 Mar; 29(2):97-103. PubMed ID: 36302234
[TBL] [Abstract][Full Text] [Related]
12. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
[TBL] [Abstract][Full Text] [Related]
13. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics.
Zhou X; Liu Y; Wang X; Li X; Xiao B
Colloids Surf B Biointerfaces; 2020 Mar; 187():110880. PubMed ID: 32098717
[TBL] [Abstract][Full Text] [Related]
14. Folic acid-modified lactoferrin nanoparticles coated with a laminarin layer loaded curcumin with dual-targeting for ulcerative colitis treatment.
Ye N; Zhao P; Ayue S; Qi S; Ye Y; He H; Dai L; Luo R; Chang D; Gao F
Int J Biol Macromol; 2023 Mar; 232():123229. PubMed ID: 36642354
[TBL] [Abstract][Full Text] [Related]
15. Genipin-crosslinked human serum albumin coating using a tannic acid layer for enhanced oral administration of curcumin in the treatment of ulcerative colitis.
Luo R; Lin M; Zhang C; Shi J; Zhang S; Chen Q; Hu Y; Zhang M; Zhang J; Gao F
Food Chem; 2020 Nov; 330():127241. PubMed ID: 32540526
[TBL] [Abstract][Full Text] [Related]
16. Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis.
Gou S; Huang Y; Wan Y; Ma Y; Zhou X; Tong X; Huang J; Kang Y; Pan G; Dai F; Xiao B
Biomaterials; 2019 Aug; 212():39-54. PubMed ID: 31103945
[TBL] [Abstract][Full Text] [Related]
17. An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice.
Li S; Jin M; Wu Y; Jung S; Li D; He N; Lee MS
Drug Deliv; 2021 Dec; 28(1):1120-1131. PubMed ID: 34121560
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Effects of Photo-Irradiation and Curcumin-Chitosan/Alginate Nanoparticles on Tumor Necrosis Factor-Alpha-Induced Psoriasis-Like Proliferation of Keratinocytes.
Gomez C; Muangnoi C; Sorasitthiyanukarn FN; Wongpiyabovorn J; Rojsitthisak P; Rojsitthisak P
Molecules; 2019 Apr; 24(7):. PubMed ID: 30970577
[TBL] [Abstract][Full Text] [Related]
19. Curcumin improves regulatory T cells in gut-associated lymphoid tissue of colitis mice.
Zhao HM; Xu R; Huang XY; Cheng SM; Huang MF; Yue HY; Wang X; Zou Y; Lu AP; Liu DY
World J Gastroenterol; 2016 Jun; 22(23):5374-83. PubMed ID: 27340353
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy.
Li Q; Zhai W; Jiang Q; Huang R; Liu L; Dai J; Gong W; Du S; Wu Q
Int J Pharm; 2015 Jul; 490(1-2):22-31. PubMed ID: 25957703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
